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The molecular epidemiologic characteristics of penicillin-resistant pneumococci in the Netherlands
were investigated in 1995. Dutch electronic surveillance data showed that 0.7% of all pneumococci
were intermediately resistant and 0.4% were highly resistant to penicillin. From March 1995 to
March 1996, 89 penicillin-resistant isolates were collected by 39 medical microbiology laboratories.
Thirty different genotypes were observed by restriction fragment end labeling. Twenty-one DNA
types were unique, whereas 9 distinct genotypes were shared by §2 isolates. Different serogroups
were found within 6 of the 9 genetically identical clusters of penicillin-resistant isolates, suggesting
that horizontal transfer of capsular genes is common. Finally, nosocomial transmission of penicillin-
resistant pneumococci was observed among 21 elderly adults with chronic obstructive pulmonary
disease. This study demonstrates that multiple clones of penicillin-resistant pneumococci have been
introduced in the Netherlands, a country with a low prevalence of pneumococcal infection. Some
clones spread among the population in and outside hospitals.
Streptococcus pneumoniae is a common cause of serious Because of the worldwide increase in drug resistance and
the clinical implications of penicillin resistance among pneu-and life-threatening infections, such as pneumonia, bacteremia,
and meningitis, and of noninvasive infections, such as otitis mococci, we investigated the epidemiologic characteristics of
penicillin-resistant pneumococci in the Netherlands over 1 year.media and sinusitis [1]. The emergence of pneumococcal resis-
tance to penicillin, particularly in combination with other resis-
tance determinants, poses serious problems for the institution
Materials and Methods
of adequate antimicrobial therapy and subsequent reduction of
transmission. Bacterial isolates. Thirty-nine Dutch medical microbiology
laboratories participated in this study and sent all penicillin-resis-Soares et al. [2] reported the spread of a multiresistant clone
tant pneumococci isolated between March 1995 and March 1996of serotype 6B from Spain to Iceland in the late 1980s. This
to our laboratory. These 39 laboratories offer microbiologic ser-resulted in an epidemic of the clone, which was isolated with
vices to the majority of the Dutch hospitals and cover 81% ofa frequency of up to 12% in 1992 [3]. In 1991, Munoz et
the Dutch population. The participating hospitals, which provideal. [4] reported evidence for the intercontinental spread of a
medium, high, and intensive care, are distributed throughout the
multiresistant clone of S. pneumoniae serotype 23F from Spain
Netherlands. The laboratories performed susceptibility testing on
to the United States. This clone subsequently disseminated all pneumococcal isolates; all penicillin-resistant pneumococci
throughout the United States. In contrast to the clonal spread were included in this study. Duplicate patient isolates were ex-
of pneumococcal resistance, an extensive genetic diversity has cluded. Eighteen of the 39 laboratories collected surveillance data
been observed among penicillin-resistant pneumococci in on the prevalence of penicillin-resistant pneumococci in 1995.
From these data, we calculated the average prevalence of penicil-South Africa [6] and Kenya [7]. The increasing emergence of
lin-resistant pneumococci.penicillin-resistant strains in the latter countries is thought to
Eighty-nine resistant isolates (MIC §0.1 mg/L) were receivedbe due to horizontal transfer of genes of altered penicillin-
and characterized in this study. Sources were blood (n Å 4), cere-binding proteins (PBPs) with lowered affinity to penicillin and
brospinal fluid (n Å 3), sputum (n Å 60), nasopharynx (n Å 19),other b-lactam antibiotics.
pus (n Å 2), and vaginal tissue (n Å 1). We also analyzed 153
penicillin-susceptible pneumococcal isolates from Dutch patients
with meningitis (provided by J. Dankert, National Reference Cen-
Received 23 September 1996; revised 27 January 1997. ter for Bacterial Meningitis, Academic Medical Center, Amster-
Reprints or correspondence: Dr. Peter W. M. Hermans, Laboratory of Pediat- dam). This collection included all pneumococcal meningitis strains
rics, Room Ee1500, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR
isolated in the Netherlands in 1994.Rotterdam, Netherlands.
Reference strains belonging to pandemic clone 23F [4] were
The Journal of Infectious Diseases 1997;175:1413–22
isolated in Spain, South Africa, Germany, and the United Statesq 1997 by The University of Chicago. All rights reserved.
0022–1899/97/7506–0017$01.00 (provided by R. Hakenbeck, Max-Planck Institute für moleculare
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Table 1. Susceptibility of penicillin-resistant pneumococci to other classes of antibiotics.
Range of MIC
concentrations
Antibiotic tested 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 ú8
Penicillin 0.015–32 — — — 3 9 11 44 22 — — —
Cotrimoxazole 0.06–16 — — — 3 4 — 3 2 32 39 6
Doxycycline 0.06–16 — — — 34 9 1 — 4 15 15 11
Erythromycin 0.06–8 — — 4 37 5 — — 2 — 1 40
Rifampicin 0.015–4 18 57 14 — — — — — — — —
Vancomycin 0.06–8 — — — 1 18 70 — — — — —
Sparfloxacin 0.03–2 — — — 19 56 14 — — — — —
NOTE. In total, 89 pneumococci were tested for each antibiotic.
Genetik, Berlin, and F. Tenover, CDC, Atlanta). Reference strains using DNA polymerase (Goldstar; Eurogentec, Seraing, Belgium).
After the radiolabeled fragments were denatured and separatedbelonging to the pandemic clone 9V [8] were isolated in Spain
(R. Hakenbeck). electrophoretically on a 6% polyacrylamide sequencing gel con-
taining 8 M urea, the gel was transferred onto filter paper, vacuum-Biochemical characterization, serotyping, and susceptibility
testing. Isolates were confirmed as S. pneumoniae by investiga- dried (HBI, Saddlebrook, NY), and exposed for variable times
at room temperature to ECL hyperfilm (Amersham Laboratories,tion of their susceptibility to optochin and to bile solubility [9].
They were serotyped on the basis of capsular swelling (Quellung Amersham, UK). BOX PCR typing was done as described [14].
PBP genotyping. Genetic polymorphism of PBP genes 1A,reaction) observed microscopically after suspension in antisera pre-
pared at Statens Seruminstitut (Copenhagen) [10]. 2B, and 2X was investigated by restriction fragment length poly-
morphism analysis. For this purpose, we amplified the genes byThe susceptibility of pneumococcal strains was determined by
agar dilution method. The MIC was defined as the lowest concen- PCR and analyzed the digested DNA products by agarose gel
electrophoresis. PCR amplification of the PBP genes was done intration of the antimicrobial agent that prevented visible growth.
For this purpose, serial log2 concentrations of antibiotics were a 50-mL PCR buffer system containing 75 mM TRIS-HCl, pH 9.0,
20 mM (NH4)2SO4, 0.01% (wt/vol) of Tween 20, 1.5 mM MgCl2 ,prepared in agar (IsoSensitest; Oxoid, Unipath, Basingstoke, UK)
supplemented with 5% horse blood. Table 1 shows the concentra- 0.2 mM dNTP, 10 pmol of individual primers, 0.5 U of DNA
polymerase (Eurogentec), and 10 ng/mL purified chromosomaltion ranges of the various antibiotics. Pneumococcal isolates were
removed from storage at 0707C, and subcultured at 377C on Co- DNA. Cycling in a programmable thermal controller (PTC-100;
MJ Research, Watertown, MA, USA) consisted of the followinglumbia agar (Oxoid) supplemented with 5% sheep blood, using
5% CO2. Bacterial suspensions were prepared in 0.9% NaCl from steps: predenaturation at 947C for 1 min, 30 1-min cycles at 94
and 527C, 2-min cycles at 727C, and final extension at 727C for 324-h agar cultures and adjusted to a McFarland turbidity of 0.5.
Suspensions were further diluted (1:10) in saline. The inocula were min. The primers used to amplify PBP 1A, 2B, and 2X genes have
been described [4, 15, 16].applied to the test plates, using a multipoint inoculator, resulting
in Ç104 cfu per spot. MICs were read after 24 h of incubation at The amplification products (5 mL) were digested by restriction
endonuclease HinfI and separated by electrophoresis in 2.5% agarose377C with 5% CO2. Quality control strains included in each run
were S. pneumoniae ATCC 49619, S. pneumoniae 19857 (clinical gels containing 0.51 TBE (44.5 mM TRIS, 44.5 mM boric acid, 1.25
mM EDTA) and 0.1 mg/mL ethidium bromide (5 mm thick, Agaroseisolate, laboratory control), and Staphylococcus aureus ATCC
29213. MP; Boehringer Mannheim, Almere, Netherlands). Gels were run in
0.51 TBE containing 0.1 mg/mL ethidium bromide at a constantThe antimicrobial agents tested were penicillin G (Sigma, St.
Louis), erythromycin (Abbott Laboratories, Queensborough, UK), current of 20 mA for 4 h and photographed (Polaroid MP4 Land
camera; Polaroid 667 films). Before electrophoresis, samples weredoxycycline (Pfizer, Brussels), vancomycin (Eli Lilly, Indianapo-
lis), rifampicin (Sigma), cotrimoxazole (1:19 trimethoprim and mixed with a 51 concentrated layer mix consisting of 50% glycerol
in water and 0.8 mg/mL bromo phenol blue.sulfamethoxazole [Sigma]) and sparfloxacin (Rhone-Poulenc
Rorer, Vitry sur Seine, France). We used antibiotic breakpoints Computer-assisted analysis of DNA band patterns. RFEL au-
toradiographs were converted to images (Image Master DTS; Phar-to discriminate between susceptible and nonsusceptible strains in
accordance with National Committee for Clinical Laboratory Stan- macia Biotech, Uppsala, Sweden) and analyzed by computer (Win-
dows version Gelcompar software version 4; Applied Math,dards guidelines for susceptibility testing [11].
Restriction fragment end labeling (RFEL) and BOX polymerase Kortrijk, Belgium). We analyzed DNA fragments with molecular
weights of 160–400 bp after normalizing the DNA banding pat-chain reaction (PCR) typing. Pneumococcal strain typing by
RFEL was done as described by Van Steenbergen et al. [12] and terns by using the pneumococcus-specific bands present in the
RFEL banding patterns of all strains. The banding patterns wereadapted by Hermans et al. [13]. Briefly, purified pneumococcal
DNA was digested by the restriction enzyme EcoRI. The DNA analyzed by the unweighted pair group method, using arithmetic
averages [17] and by applying the Jaccard similarity coefficient torestriction fragments were end labeled at 727C with [a-32P]dATP
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Table 2. Resistance patterns of penicillin-resistant pneumococci. was exceptional, consisting of a group of DNA types with
homologies §91%. Due to the presence of three very faint
Strains with penicillin MIC bands that variably appeared in this type, even when a single
Resistance
strain was analyzed repeatedly, we considered these 9 strainspattern £0.5 (n Å 23) 1 (n Å 44) 2 (n Å 22)
as a group sharing RFEL type 19. Genetic clustering shown
P 4 0 0 by RFEL analysis was confirmed by BOX PCR typing. Except
PC 10 14 11 for RFEL type 15, the RFEL clusters also displayed identical
PD 1 0 0 genotypes by BOX PCR. The dichotomy observed in RFEL
PE 0 1 0
cluster type 15 using BOX PCR typing was restricted to aPCD 3 3 0
single DNA fragment band difference (data not shown).PCE 1 4 2
PDE 1 0 0 The degree of genetic clustering was much higher among
PCDE 3 22 9 the penicillin-resistant strains compared with a group of 153
penicillin-susceptible strains, since the DNA banding patternsNOTE. P, penicillin G; C, cotrimoxazole; D, doxycycline; E, erythromy-
of only 51 penicillin-susceptible strains (33%) were observedcin.
more than once (figure 1B). In addition, no overlap was ob-
served among RFEL types between penicillin-resistant and
-susceptible pneumococci (data not shown).peaks [18]. Computer-assisted analysis and methods and algo-
Within clusters of identical genotypes, different serotypesrithms followed the manufacturer’s instructions. A tolerance of
were observed. Six of the 9 RFEL clusters displayed §2 sero-1.5% in band positions was allowed during comparison of DNA
patterns. Identical DNA types were arbitrarily defined as RFEL types. The predominant RFEL type 15 harbored 11 strains of
homologies ú95%. serogroup 19 and 11 strains of serogroup 23. These 2 distinct
serogroups in RFEL type 15 were congruent with the 2 different
BOX PCR types observed within this RFEL type. The predomi-
Results
nant RFEL type 23 comprised 11 strains of serogroup 9 and 7
of serogroup 14 (figures 1A, 2, table 3). Furthermore, differentMolecular epidemiology of Dutch penicillin-resistant pneu-
mococci. The average prevalence of penicillin-resistant pneu- resistance patterns were observed within clusters of identical
RFEL types. The predominant RFEL type 15 harbored themococci in 1995 was calculated using electronic surveillance
data from 18 of 39 Dutch medical microbiology laboratories resistance patterns PCD, PCDE, and PCE. RFEL type 23 dis-
played PC, PCDE, PCE, PDE, and PE patterns (figure 1A,participating in the study. By combined data analysis, 2653
pneumococci were isolated by the laboratories. Of these, 0.7% table 3). RFEL type 15 was identical to the pandemic clone
23F (initially isolated in Spain [4]) when the Dutch RFEL(n Å 19) were intermediately resistant (MIC Å 0.1–1 mg/L)
and 0.4% (n Å 11) were highly resistant (MIC ú 1 mg/L). types were compared with a computerized data library of ú50
distinct RFEL types, which represent drug-resistant pneumo-From March 1995 to March 1996, the 39 laboratories sent us
89 penicillin-resistant strains (MIC§0.1 mg/L): 67 (75%) were cocci found worldwide. RFEL type 23 was identical to clone
9V, which spread from Spain to France [8] (figure 2).intermediately resistant to penicillin, and 22 (25%) were highly
resistant. Most of these strains had MICs near the resistance The 89 penicillin-resistant strains and the collection of sus-
ceptible strains were further analyzed by PBP typing. Twenty-breakpoint, 1 mg/L penicillin (table 1).
Forty-eight percent of the penicillin-resistant strains were four distinct PBP types were observed among the resistant
strains (figure 1A, table 3). PBP type 1 was observed in 48 ofresistant to erythromycin, 46% to doxycycline, and 93% to
cotrimoxazole. The MIC distributions of erythromycin, doxy- 89 strains. This PBP cluster included a significant proportion
of the strains displaying the predominant RFEL types 15, 23,cycline, and cotrimoxazole were clearly bimodal. The MIC
distribution of rifampicin, vancomycin, and sparfloxacin did and 26 (figure 1A, table 3). Nine types were present among
the susceptible group of strains. No overlap of PBP types wasnot show a distinct resistant subpopulation. The latter antibiot-
ics were active against all isolates. Table 2 summarizes the observed between the penicillin-resistant and -susceptible
strains (data not shown).resistance patterns of the penicillin-resistant pneumococci and
shows that those with MICs §1 mg/L tended to be more fre- Nosocomial transmission of multiresistant pneumococci in
the Netherlands. We investigated the epidemiologic relat-quently resistant to §4 antibiotics (resistance pattern PCDE).
The penicillin-resistant pneumococci were analyzed for ge- edness of the patients infected with resistant pneumococci with
identical RFEL types (homology §95%). The isolates belong-notype using RFEL. Twenty-one DNA types were uniquely
present, and 9 distinct genotypes were shared by §2 isolates. ing to RFEL cluster 15 were isolated by nine laboratories. Two
laboratories isolated RFEL type 15 pneumococci from 4 andThe latter group comprised 68 strains, 76% of the collection
(figure 1A, table 3). Identical DNA types were arbitrarily de- 11 patients, respectively. The patients’ clinical histories re-
vealed that nosocomial transmission of multiresistant pneumo-fined as RFEL homologies ú95%. However, RFEL type 19
/ 9d2a$$ju01 04-02-97 11:56:24 jinfas UC: J Infect
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Table 3. Genotypic and phenotypic properties of penicillin-resistant Within each of the two hospital outbreaks, the resistance pattern
pneumococci within 9 restriction fragment end labeling (RFEL) clus- and the isolate serogroups were identical. However, the two
ters. hospitals had different resistance patterns and strain serogroups,
indicating significant genetic diversity among these groups.RFEL
The isolates belonging to RFEL cluster 19 were isolatedcluster PBP Resistance
type type Serogroup pattern No.* of strains in two separate hospitals from 4 and 5 patients, respectively.
Investigation of the patients’ clinical histories pointed to a
15 1 19 PCDE 9,† 1, 1 clonal spread of multiresistant pneumococci within and be-
15 1 23 PCE 3,† 1
tween the hospitals. Similar to the outbreaks in hospitals 1 and15 1 23 PCD 1, 1, 1, 1
8, the patients also had chronic obstructive pulmonary disease15 1 23 PCDE 1, 1
15 2 23 PCDE 1 and penicillin-resistant pneumococci isolated from sputum.
Figure 3C demonstrates the time period during which patients23 1 9 PC 2, 1, 1, 1, 1, 1, 1
occupied the same rooms in hospitals 12 and 20. Since 1 of23 1 9 PCDE 1
23 1 9 PCE 1 the patients was transferred from hospital 12 to hospital 20
23 3 9 PCE 1 (figure 3C), we assume this patient was the vehicle for the
23 1 14 PC 1, 1, 1, 1, 1 interhospital transmission of the multidrug-resistant strain.
23 1 14 PE 1
23 1 14 PDE 1
Discussion26 1 14 PC 2, 1, 1, 1
26 4 14 PC 3
We investigated the molecular epidemiology of 89 penicil-26 5 14 PC 1
lin-resistant pneumococcal strains collected from March 1995
19 6 15 PCDE 5,† 4† to March 1996 throughout the Netherlands, a country where
4 9 23 P 1, 1
pneumococcal resistance remains rare. Of the isolates, 0.7%4 9 23 PC 1
had intermediate-level resistance and 0.4% had high-level resis-
28 1 19 PC 1 tance. Most strains had MICs near the resistance breakpoint
28 1 23 PCDE 1
(1–2 mg/L). Therefore, infections by these organisms (other
20 17 19 PCDE 1 than in cases of meningitis) are expected to respond to intrave-
20 17 23 PC 1 nous treatment with penicillin.
6 21 6 PCDE 1 Similar low rates of resistance have been reported in neigh-
6 21 15 PCDE 1 boring countries (e.g., Germany [19] and the UK [20]), al-
though in the United Kingdom, resistance has risen from 1.5%17 18 19 PCDE 1
17 22 14 PCDE 1 in 1990 to 3.9% in 1995. In other European countries (e.g.,
France [21] and Spain [22]), penicillin-resistant pneumococci
NOTE. Twenty-one strains with unique RFEL types are not included in
are much more common. Many of our penicillin-resistantthis table. PBP, penicillin-binding protein; P, penicillin G; C, cotrimoxazole;
D, doxycycline; E, erythromycin. strains were also resistant to cotrimoxazole, doxycycline, and
* No. sent by individual laboratories. erythromycin, similar to findings in the United States [23].
† Confirmed hospital outbreaks.
Rifampicin, vancomycin, and sparfloxacin were still active
against all isolates. In addition, the penicillin-resistant pneumo-
cocci with MICs §1 mg/L tended to be more frequently multi-
ply resistant against 4 antibiotics (resistance pattern PCDE).cocci had occurred in two hospitals, involving 3 and 9 patients.
In both hospitals, the patients had chronic obstructive pulmo- We hypothesize that horizontal cotransfer of antibiotic resis-
tance genes other than PBP genes occurs frequently amongnary disease, and penicillin-resistant pneumococci were iso-
lated from sputum. The time period during which patients pneumococci with a high level of resistance to penicillin.
Thirty distinct RFEL types were observed among the penicil-shared the same rooms in hospitals 1 and 8 is shown in figure
3A, B, respectively. lin-resistant isolates. Pneumococcal strains with identical
RFEL types were invariably received from two or more labora-An epidemiologic link between hospitals 1 and 8 could not
be identified. Of interest was that patient 3, who was involved tories. The degree of genetic homogeneity was significantly
higher than with a group of 153 penicillin-susceptible strainsin the pneumococcal outbreak in hospital 1, had a multiresistant
pneumococcus isolated in 1993. RFEL analysis clearly demon- isolated from patients with meningitis. In addition, no overlap
was observed among RFEL types between penicillin-resistantstrated that the strain isolated in 1993 had an RFEL type identical
to that observed in 1995 (data not shown). These data suggest and -susceptible pneumococci. These observations suggest that
despite the extremely low prevalence of penicillin resistancethe patient carried the multiresistant pneumococcus several
years and was likely the index case in the nosocomial outbreak. in the Netherlands, multiple clones of penicillin-resistant pneu-
/ 9d2a$$ju01 04-02-97 11:56:24 jinfas UC: J Infect
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Figure 2. Genetic homology between Dutch peni-
cillin-resistant pneumococci of restriction fragment
end labeling types 15 and 23 and strains belonging to
pandemic clones 23F (j) and 9V (l). Serogroups (S)
are also depicted.
mococci have been introduced. The capacity of some penicillin- that clone 9V (RFEL type 23) harbors at least 2 capsular sero-
groups: 9 and 14.resistant pneumococci to spread in the Netherlands is evident,
but a widespread epidemic of resistant pneumococcal strains, PBP genotype analysis revealed that PBP type 1 was pre-
dominant in 48 of 89 resistant strains. Of interest, PBP type 1observed in other countries [2, 4, 5, 8, 24–29], has not yet
materialized. Clearly, the very young and the elderly are at the strains represented 8 distinct RFEL types. Since the genetic
relatedness of the RFEL types is low, we hypothesize thathighest risk for such an epidemic. Factors such as frequent use
of b-lactam antibiotics may contribute to this risk. identical PBP types result from horizontal transfer of PBP
genes coding for low-affinity PBPs within these geneticallySerogroups 14 (n Å 22), 23 (n Å 20), 19 (n Å 16), 9 (n Å
12), and 15 (n Å 11) were frequently encountered. Different distinct families. Detailed characterization of the PBP genes to
investigate their clonal relatedness is underway.serogroups were found in 6 of 9 genetic clusters of penicillin-
resistant isolates. This suggests frequent horizontal transfer of Within four hospitals, the penicillin-resistant S. pneumoniae
isolates invariably displayed identical RFEL type, resistancecapsular genes in vivo. The high frequency of capsular transfer
may have consequences with regard to the outcome of the pattern, and serogroup. Two hospital outbreaks involving 3 and
9 patients were caused by isolates of RFEL type 15. Case-current vaccine strategy, which focuses on the use of capsular
polysaccharides representing a restricted number of capsular history studies of the patients did not suggest hospital-to-hospi-
tal transmission. Since the resistance patterns and the serotypestypes. The use of multivalent conjugate vaccines may shift the
capsular distribution toward capsular types not represented in differed among the isolates from the two hospitals, we conclude
that these nosocomial outbreaks were caused by two distinctthe vaccines.
When the RFEL types were compared with those in a compu- lineages derived from the alarming clone 23F.
In two other hospitals, nosocomial transmission of strains dis-terized data library ofú80 distinct drug-resistant pneumococci
collected worldwide (Hermans PWM, unpublished data), RFEL playing RFEL type 19 was observed. Interhospital transmission
was highly suggestive, since 1 patient was transferred from onetype 15 was identical to the pandemic clone 23F initially iso-
lated in Spain [4]. Similar to our observations, Coffey and hospital to the other, and the resistance pattern and the serogroup
of the strains from the two hospitals were identical. RFEL typecoworkers [15] reported that the pandemic clone 23F harbors
both serogroups 23 and 19. In addition, Barnes et al. [30] 19 did not show any genetic relatedness with the DNA banding
patterns shown in the international data library of ú80 distinctreported capsular transformation of the latter clone from sero-
type 23F to serotype 14. In addition, RFEL type 23 resembled RFEL types representing drug-resistant pneumococci collected
worldwide (Hermans P. W. M., unpublished data). The patientsthe Spanish/French clone 9V [8]. So far, capsular diversity
within clone 9V has not been observed. Our data demonstrate infected nosocomially with penicillin-resistant pneumococci in-
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Figure 3. Schematic drawing in-
dicating nosocomial transmission of
penicillin-resistant pneumococci in
hospitals 1 (A), 8 (B), and 12 (open
bars) and 20 (shaded bars) (C). Let-
ters on time axis indicate months of
year; vertical lines in bars indicate
time points when pneumococci were
isolated from patients.
variably had chronic obstructive pulmonary disease. We therefore settings, such as prisons [39], shelters for the homeless [40], nurs-
ing homes [41], and day care facilities [30, 42, 43].conclude that this disease is an important risk factor for the acquisi-
tion and spread of penicillin-resistant pneumococci. RFEL types 15, 19, 23, and 26 were most frequently ob-
served among Dutch penicillin-resistant isolates. Only two lab-Several pneumococcal outbreaks in hospitals have been reported
[31–38], and outbreaks have been investigated in other institutional oratories collected isolates with RFEL type 19, whereas RFEL
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